Codexis Inc (CDXS)
2.655
0.00 (0.00%)
USD |
NASDAQ |
Apr 26, 16:00
2.655
0.00 (0.00%)
After-Hours: 17:10
Codexis Total Return Level: 2.65 for April 25, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
April 25, 2024 | 2.65 |
April 24, 2024 | 2.80 |
April 23, 2024 | 2.90 |
April 22, 2024 | 2.86 |
April 19, 2024 | 2.83 |
April 18, 2024 | 2.80 |
April 17, 2024 | 2.76 |
April 16, 2024 | 2.73 |
April 15, 2024 | 2.69 |
April 12, 2024 | 2.87 |
April 11, 2024 | 3.11 |
April 10, 2024 | 3.13 |
April 09, 2024 | 3.23 |
April 08, 2024 | 3.21 |
April 05, 2024 | 3.19 |
April 04, 2024 | 3.21 |
April 03, 2024 | 3.34 |
April 02, 2024 | 3.33 |
April 01, 2024 | 3.485 |
March 28, 2024 | 3.49 |
March 27, 2024 | 3.51 |
March 26, 2024 | 3.45 |
March 25, 2024 | 3.45 |
March 22, 2024 | 3.45 |
March 21, 2024 | 3.49 |
Date | Value |
---|---|
March 20, 2024 | 3.49 |
March 19, 2024 | 3.27 |
March 18, 2024 | 3.25 |
March 15, 2024 | 3.33 |
March 14, 2024 | 3.20 |
March 13, 2024 | 3.38 |
March 12, 2024 | 3.47 |
March 11, 2024 | 3.61 |
March 08, 2024 | 3.47 |
March 07, 2024 | 3.66 |
March 06, 2024 | 3.64 |
March 05, 2024 | 3.76 |
March 04, 2024 | 4.205 |
March 01, 2024 | 4.61 |
February 29, 2024 | 4.65 |
February 28, 2024 | 3.72 |
February 27, 2024 | 4.15 |
February 26, 2024 | 3.20 |
February 23, 2024 | 3.03 |
February 22, 2024 | 2.87 |
February 21, 2024 | 2.85 |
February 20, 2024 | 2.89 |
February 16, 2024 | 3.18 |
February 15, 2024 | 3.24 |
February 14, 2024 | 2.82 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
1.50
Minimum
Sep 25 2023
41.78
Maximum
Nov 08 2021
13.20
Average
12.69
Median
Oct 07 2020
Total Return Level Benchmarks
Sutro Biopharma Inc | 3.42 |
Avidity Biosciences Inc | 23.83 |
Taysha Gene Therapies Inc | 2.30 |
Janux Therapeutics Inc | 47.10 |
Tango Therapeutics Inc | 7.33 |